详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Chen, Xiaofeng[1,2,3,4,5,6,7,8] *

; Zhang, Xinyi[1,2,3,4,5,6,7,8] ; Qiu, Jinrong[1,2,3,4,5,6,7,8] ; Zheng, Tongsen[1,2,3,4,5,6,7,8] ; Qiu, Hong[1,2,3,4,5,6,7,8]

; Tian, Yitong[1,2,3,4,5,6,7,8] ; Pan, Lanlan[1,2,3,4,5,6,7,8] ; Zhang, Jiaguang[1,2,3,4,5,6,7,8] ; Chen, Yizhang[1,2,3,4,5,6,7,8] ; Shen, Haoyang[1,2,3,4,5,6,7,8] ; Wang, Chao[1,2,3,4,5,6,7,8]

;

单位： [1]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China [2]Suzhou Municipal Hosp, Dept Oncol, Suzhou, Peoples R China [3]Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Peoples R China [4]Eastern Hepatobibiary Surg Hosp, Shanghai, Peoples R China [5]Harbin Med Univ, Canc Hosp, Haerbin, Peoples R China [6]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China [7]Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Jiangsu Prov Hosp, Nanjing, Peoples R China [8]Guangzhou Gloria Biosci Co Ltd, Beijing, Peoples R China

出处：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 ONCOLOGY

最新[2024]版：

Q1 ONCOLOGY

第一作者：

第一作者单位： [1]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China [2]Suzhou Municipal Hosp, Dept Oncol, Suzhou, Peoples R China [3]Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Peoples R China [4]Eastern Hepatobibiary Surg Hosp, Shanghai, Peoples R China [5]Harbin Med Univ, Canc Hosp, Haerbin, Peoples R China [6]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China [7]Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Jiangsu Prov Hosp, Nanjing, Peoples R China [8]Guangzhou Gloria Biosci Co Ltd, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

A single-arm, open-label, phase. study investigating anti-HER2 ADC plus anti-PD-1 antibody in patients with unresectable locally advanced or metastatic BTC with HER2 overexpression

文献详情